Eduardo Cazap

2.8k total citations
41 papers, 1.3k citations indexed

About

Eduardo Cazap is a scholar working on Oncology, Economics and Econometrics and Genetics. According to data from OpenAlex, Eduardo Cazap has authored 41 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Oncology, 14 papers in Economics and Econometrics and 12 papers in Genetics. Recurrent topics in Eduardo Cazap's work include Global Cancer Incidence and Screening (21 papers), Economic and Financial Impacts of Cancer (12 papers) and BRCA gene mutations in cancer (11 papers). Eduardo Cazap is often cited by papers focused on Global Cancer Incidence and Screening (21 papers), Economic and Financial Impacts of Cancer (12 papers) and BRCA gene mutations in cancer (11 papers). Eduardo Cazap collaborates with scholars based in United States, Brazil and Argentina. Eduardo Cazap's co-authors include Benjamin O. Anderson, Rajendra Badwe, Clement Adebamowo, Nagi S. El Saghir, Joe B. Harford, Isabel V. Otero, Cheng Har Yip, Hussein Khaled, Ahmed Elzawawy and Bengt Jönsson and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Cancer.

In The Last Decade

Eduardo Cazap

38 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eduardo Cazap United States 19 844 272 241 214 190 41 1.3k
Jem Rashbass United Kingdom 17 820 1.0× 426 1.6× 144 0.6× 150 0.7× 273 1.4× 39 1.5k
Nazik Hammad Canada 19 568 0.7× 161 0.6× 230 1.0× 281 1.3× 115 0.6× 84 1.2k
Arduino Verdecchia Italy 22 973 1.2× 285 1.0× 148 0.6× 83 0.4× 258 1.4× 35 1.6k
Therese M. Mulvey United States 12 697 0.8× 177 0.7× 539 2.2× 356 1.7× 101 0.5× 45 1.5k
Maureen Joffe South Africa 18 721 0.9× 219 0.8× 116 0.5× 143 0.7× 293 1.5× 76 1.1k
Yanin Chávarri-Guerra Mexico 19 672 0.8× 272 1.0× 141 0.6× 278 1.3× 61 0.3× 81 1.3k
Roy Beveridge United States 22 658 0.8× 233 0.9× 222 0.9× 284 1.3× 90 0.5× 62 1.5k
Nina Horowitz United States 16 627 0.7× 674 2.5× 326 1.4× 123 0.6× 132 0.7× 50 1.4k
Jane Bryce Italy 19 978 1.2× 151 0.6× 190 0.8× 156 0.7× 212 1.1× 41 1.8k
Nancy Roach United States 19 788 0.9× 302 1.1× 189 0.8× 275 1.3× 423 2.2× 35 1.7k

Countries citing papers authored by Eduardo Cazap

Since Specialization
Citations

This map shows the geographic impact of Eduardo Cazap's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eduardo Cazap with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eduardo Cazap more than expected).

Fields of papers citing papers by Eduardo Cazap

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eduardo Cazap. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eduardo Cazap. The network helps show where Eduardo Cazap may publish in the future.

Co-authorship network of co-authors of Eduardo Cazap

This figure shows the co-authorship network connecting the top 25 collaborators of Eduardo Cazap. A scholar is included among the top collaborators of Eduardo Cazap based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eduardo Cazap. Eduardo Cazap is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Martín, Claudio, et al.. (2022). Highlights of the ‘I Congress ecancer Choosing Wisely’ March 30 and 31, 2022 Santa Cruz, Bolivia. ecancermedicalscience. 16. 1436–1436.
2.
Werutsky, Gustavo, Carlos H. Barrios, Andrés F. Cardona, et al.. (2021). Perspectives on emerging technologies, personalised medicine, and clinical research for cancer control in Latin America and the Caribbean. The Lancet Oncology. 22(11). e488–e500. 25 indexed citations
3.
Cazap, Eduardo, et al.. (2018). Global Acceptance of Biosimilars: Importance of Regulatory Consistency, Education, and Trust. The Oncologist. 23(10). 1188–1198. 40 indexed citations
4.
Akaza, Hideyuki, N. Kawahara, Takashi Fukuda, et al.. (2015). Roundtable Discussion at the UICC World Cancer Congress: Looking Toward the Realization of Universal Health Coverage for Cancer in Asia. Asian Pacific Journal of Cancer Prevention. 16(1). 1–8. 5 indexed citations
5.
Cazap, Eduardo. (2014). Personalised Cancer Care – A Global Perspective. European Oncology & Haematology. 10(2). 104–104. 1 indexed citations
6.
7.
Cazap, Eduardo. (2012). Abstract SY26-01: Screening and cancer prevention in underdeveloped environments: A global view. Cancer Research. 72(8_Supplement). SY26–1. 2 indexed citations
8.
Are, Chandrakanth, Shireen S. Rajaram, Madhuri Are, et al.. (2012). A review of global cancer burden: Trends, challenges, strategies, and a role for surgeons. Journal of Surgical Oncology. 107(2). 221–226. 87 indexed citations
9.
Saghir, Nagi S. El, Clement Adebamowo, Benjamin O. Anderson, et al.. (2011). Breast cancer management in low resource countries (LRCs): Consensus statement from the Breast Health Global Initiative. The Breast. 20. S3–S11. 167 indexed citations
10.
Anderson, Benjamin O., Eduardo Cazap, Nagi S. El Saghir, et al.. (2011). Optimisation of breast cancer management in low-resource and middle-resource countries: executive summary of the Breast Health Global Initiative consensus, 2010. The Lancet Oncology. 12(4). 387–398. 232 indexed citations
11.
Harford, Joe B., Isabel V. Otero, Benjamin O. Anderson, et al.. (2011). Problem solving for breast health care delivery in low and middle resource countries (LMCs): consensus statement from the Breast Health Global Initiative. The Breast. 20. S20–S29. 50 indexed citations
12.
Sacco, RL, David R. Holmes, Susan B. Shurin, et al.. (2011). Accelerating progress on non-communicable diseases. The Lancet. 382(9895). e4–e5. 26 indexed citations
13.
Adams, Cary, et al.. (2011). The World Cancer Declaration: from resolution to action. The Lancet Oncology. 12(12). 1091–1092. 6 indexed citations
14.
Yip, Cheng Har, Eduardo Cazap, Benjamin O. Anderson, et al.. (2011). Breast cancer management in middle-resource countries (MRCs): Consensus statement from the Breast Health Global Initiative. The Breast. 20. S12–S19. 48 indexed citations
15.
Mbanya, Jean Claude, S. Bertel Squire, Eduardo Cazap, & Pekka Puska. (2010). Mobilising the world for chronic NCDs. The Lancet. 377(9765). 536–537. 15 indexed citations
16.
Cazap, Eduardo, Antônio C. Buzaid, Horacio Astudillo‐de la Vega, et al.. (2009). Breast cancer in Latin America: Experts perceptions compared with medical care standards. The Breast. 19(1). 50–54. 11 indexed citations
17.
Jatoi, Ismail, K. Michael Cummings, & Eduardo Cazap. (2009). Global Tobacco Problem Getting Worse, Not Better. Journal of Oncology Practice. 5(1). 21–23. 5 indexed citations
18.
Kooten, Maximiliano Van, et al.. (1999). Single-agent gemcitabine in pretreated patients with non-small-cell lung cancer: results of an Argentinean multicentre phase II trial. British Journal of Cancer. 81(5). 846–849. 21 indexed citations
19.
Cazap, Eduardo, et al.. (1988). Argentina. Journal of Cancer Education. 3(2). 111–115. 7 indexed citations
20.
Cazap, Eduardo, et al.. (1988). Phase II trial of 4'-epi-doxorubicin in locally advanced or metastatic gastric cancer.. PubMed. 74(3). 313–5. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jem Rashbass Breakdown of academic impact, for papers by Nazik Hammad Breakdown of academic impact, for papers by Arduino Verdecchia Breakdown of academic impact, for papers by Therese M. Mulvey Breakdown of academic impact, for papers by Maureen Joffe Breakdown of academic impact, for papers by Yanin Chávarri-Guerra Breakdown of academic impact, for papers by Roy Beveridge Breakdown of academic impact, for papers by Nina Horowitz Breakdown of academic impact, for papers by Jane Bryce Breakdown of academic impact, for papers by Nancy Roach
Rankless by CCL
2026